查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585727

输血设备市场：按产品、最终用户划分 - 全球预测 2025-2030 年

Blood Transfusion Devices Market by Product (Apheresis Device, Blood Bag, Blood Component Separator), End-user (Ambulatory Surgical Centres, Blood Bank, Hospital) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年输血器材市值为41.2亿美元，预计2024年将达44亿美元，复合年增长率为7.18%，到2030年将达67亿美元。

输血器械包括用于采集、储存、处理和输注血液及其成分的各种设备和器材。这些设备在手术期间控制失血、治疗贫血和支持创伤復原方面发挥关键作用，凸显了对这些设备的需求。应用范围包括医院、门诊手术中心和血库，最终用户是医疗保健专业人员，他们要求血液处理和输血过程的准确性、安全性和效率。输血设备市场主要是由慢性病盛行率上升、外科手术数量增加以及对捐血和输血安全意识的增强所推动的。技术进步，例如提高安全性并最大限度减少人为错误的自动输血设备和系统的开发，正在推动市场成长。然而，市场扩张受到与输血相关的风险（例如感染疾病传播）以及设备采购和维护相关的高成本的限制。此外，监管挑战也是市场进入的障碍。儘管面临这些挑战，医疗基础设施正在改善的新兴和不断扩大的市场正在出现机会。公司可以透过专注于适合资源匮乏环境的经济实惠、便携式且易于使用的设备来利用这些机会。生物相容性感测器技术和血液分离技术的改进等领域有望加速创新。此外，投资于医务人员的培训计划可以提高这些设备的采用和最佳使用，透过确保其品质和安全性来使其对医疗机构有吸引力。与监管机构合作并遵守严格的安全通讯协定可以提高产品接受度并减少挑战。该市场的性质是动态的，不断变化的医疗保健需求和技术进步往往推动创新，这表明竞争激烈的市场具有巨大的探索和策略成长空间。

主要市场统计
基准年[2023] 41.2亿美元
预测年份 [2024] 44亿美元
预测年份 [2030] 67亿美元
复合年增长率（%） 7.18%

市场动态：快速发展的输血设备市场的关键市场洞察

供需的动态交互作用正在改变输血设备市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 血液相关疾病和癌症流行
    • 政府支持的意识提升宣传活动和对血液製品筛检的需求不断增长
    • 全球交通事故和手术数量增加
  • 市场限制因素
    • 输血器具製造成本高
  • 市场机会
    • 技术先进的筛检分析仪的可用性迅速增加
    • 持续研究改善输血装置的功能
  • 市场挑战
    • 严格的核准规定

波特五力：驾驭输血器材市场的策略工具

波特的五力框架是了解输血设备市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解输血设备市场的外部影响

外部宏观环境因素在塑造输血器材市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解输血器材市场竞争状况

对输血设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV定位矩阵输血装置市场供应商绩效评估

FPNV定位矩阵是评估输血器材市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划输血设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对输血设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 血液相关疾病和癌症的盛行率

全世界

      • 随着政府的支持和对经过测试的血液製品的需求，宣传宣传活动不断扩大
      • 世界各地的交通事故和手术数量正在增加。
    • 抑制因素
      • 输血器生产成本高
    • 机会
      • 技术先进的筛检分析仪的采用迅速增加
      • 持续研究改善输血装置的功能
    • 任务
      • 严格核准监理政策
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章输血设备市场：副产品

  • 血浆分离装置
  • 血袋
  • 血液成分分离装置
  • 血液混合器
  • 消耗品和用品
  • 点滴帮浦
  • 病原体减少系统

第七章 输血设备市场：依最终使用者分类

  • 门诊手术中心
  • 血库
  • 医院

第八章美洲输血器械市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太输血器材市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲输血器材市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • B. Braun SE
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Ecomed Solutions
  • EryPharm
  • F.Hoffman-La Roche AG
  • Fresenius Kabi Malaysia Sdn. Bhd.
  • Fresenius SE & Co. KGaA
  • Grifols, SA
  • Haemonetics Corporation
  • Jiangsu Kangjin Medical Instrument Co.,Ltd.
  • Kawasumi Laboratories, Inc.
  • Macopharma
  • Nipro Medical Corporation
  • Ortho-Clinical Diagnostics, Inc.
  • Quotient Suisse SA
  • Sarstedt AG & Co. KG
  • Siemens AG
  • SURU INTERNATIONAL PVT. LTD.
  • Terumo Corporation
Product Code: MRR-521BAA36EADD

The Blood Transfusion Devices Market was valued at USD 4.12 billion in 2023, expected to reach USD 4.40 billion in 2024, and is projected to grow at a CAGR of 7.18%, to USD 6.70 billion by 2030.

Blood transfusion devices encompass a range of equipment and instruments used to collect, store, process, and transfuse blood and its components. The necessity of these devices is underscored by their critical role in addressing blood loss during surgeries, treating anemia, and supporting traumatic injury recovery. Their applications stretch across hospitals, ambulatory surgical centers, and blood banks, with end-users being medical professionals who demand precision, safety, and efficiency in blood handling and transfusion processes. The market for blood transfusion devices is primarily driven by the rising prevalence of chronic diseases, increasing surgical procedures, and growing awareness regarding blood donation and transfusion safety. Technological advancements, such as the development of automated transfusion devices and systems that enhance safety and minimize human error, add momentum to market growth. However, market expansion faces limitations such as the risks associated with blood transfusion, including the transmission of infectious diseases, and the high costs related to device procurement and maintenance. Furthermore, regulatory challenges pose hurdles for market players. Despite these challenges, opportunities are emerging in developing and expanding markets where healthcare infrastructure is improving. Companies can capitalize on these opportunities by focusing on affordable, portable, and easy-to-use devices that suit low-resource settings. Innovation is poised to thrive in areas like biocompatible sensor technology and improved blood separation techniques. Moreover, investing in training initiatives for medical staff could improve the adoption and optimized use of these devices, enticing healthcare facilities with assurances of quality and safety. Collaboration with regulatory bodies and adherence to strict safety protocols can enhance product acceptance and mitigate challenges. The nature of this market is dynamic, with innovations often steered by evolving healthcare needs and technological advancements, suggesting a competitive landscape with robust scope for research and strategic growth.

KEY MARKET STATISTICS
Base Year [2023] USD 4.12 billion
Estimated Year [2024] USD 4.40 billion
Forecast Year [2030] USD 6.70 billion
CAGR (%) 7.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Transfusion Devices Market

The Blood Transfusion Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of blood-related disorders and cancer globally
    • Growing awareness campaigns with government support and demand for screened blood products
    • Rising cases of road accidents and increase in number of surgeries worldwide
  • Market Restraints
    • High cost of production of blood transfusion devices
  • Market Opportunities
    • Surge in availability of technologically advanced screening analyzers
    • Ongoing research to improve the functionality of blood transfusion devices
  • Market Challenges
    • Strict regulatory policies for approval

Porter's Five Forces: A Strategic Tool for Navigating the Blood Transfusion Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Transfusion Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Transfusion Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Transfusion Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Transfusion Devices Market

A detailed market share analysis in the Blood Transfusion Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Transfusion Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Transfusion Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Transfusion Devices Market

A strategic analysis of the Blood Transfusion Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Transfusion Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Baxter International Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Ecomed Solutions, EryPharm, F.Hoffman-La Roche AG, Fresenius Kabi Malaysia Sdn. Bhd., Fresenius SE & Co. KGaA, Grifols, S.A., Haemonetics Corporation, Jiangsu Kangjin Medical Instrument Co.,Ltd., Kawasumi Laboratories, Inc., Macopharma, Nipro Medical Corporation, Ortho-Clinical Diagnostics, Inc., Quotient Suisse SA, Sarstedt AG & Co. KG, Siemens AG, SURU INTERNATIONAL PVT. LTD., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Blood Transfusion Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Apheresis Device, Blood Bag, Blood Component Separator, Blood Mixer, Consumables & Supplies, Infusion Pumps, and Pathogen Reduction System.
  • Based on End-user, market is studied across Ambulatory Surgical Centres, Blood Bank, and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of blood-related disorders and cancer

globally

      • 5.1.1.2. Growing awareness campaigns with government support and demand for screened blood products
      • 5.1.1.3. Rising cases of road accidents and increase in number of surgeries worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of production of blood transfusion devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in availability of technologically advanced screening analyzers
      • 5.1.3.2. Ongoing research to improve the functionality of blood transfusion devices
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory policies for approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Transfusion Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Apheresis Device
  • 6.3. Blood Bag
  • 6.4. Blood Component Separator
  • 6.5. Blood Mixer
  • 6.6. Consumables & Supplies
  • 6.7. Infusion Pumps
  • 6.8. Pathogen Reduction System

7. Blood Transfusion Devices Market, by End-user

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centres
  • 7.3. Blood Bank
  • 7.4. Hospital

8. Americas Blood Transfusion Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Blood Transfusion Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Blood Transfusion Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. B. Braun SE
  • 3. Baxter International Inc.
  • 4. Becton Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. Ecomed Solutions
  • 8. EryPharm
  • 9. F.Hoffman-La Roche AG
  • 10. Fresenius Kabi Malaysia Sdn. Bhd.
  • 11. Fresenius SE & Co. KGaA
  • 12. Grifols, S.A.
  • 13. Haemonetics Corporation
  • 14. Jiangsu Kangjin Medical Instrument Co.,Ltd.
  • 15. Kawasumi Laboratories, Inc.
  • 16. Macopharma
  • 17. Nipro Medical Corporation
  • 18. Ortho-Clinical Diagnostics, Inc.
  • 19. Quotient Suisse SA
  • 20. Sarstedt AG & Co. KG
  • 21. Siemens AG
  • 22. SURU INTERNATIONAL PVT. LTD.
  • 23. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. BLOOD TRANSFUSION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD TRANSFUSION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BLOOD TRANSFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BLOOD TRANSFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD TRANSFUSION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD TRANSFUSION DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COMPONENT SEPARATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD MIXER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONSUMABLES & SUPPLIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PATHOGEN REDUCTION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. BLOOD TRANSFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 106. BLOOD TRANSFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023